Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effectiveness and safety of different doses of ASP1707 versus placebo for endometriosis-associated pelvic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• ASP1707

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Endometriosis | Phase 2 | Status: COMPLETED